PA
ECG

PharVision Advisers’s Everus Construction Group ECG Stock Holding History

PharVision Advisers’s Portfolio ECG Stock Details ECG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,212
Closed -$275K – 685
2025
Q4 		$275K Buy
+3,212
New +$287K 0.14% 329

Other funds holding ECG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

PharVision Advisers's ECG Position: Q1 2026 in Review

PharVision Advisers sold out of Everus Construction Group (ECG) in Q1 2026, closing a stake of 3,212 shares — an estimated $275K sold.

PharVision Advisers first reported a position in ECG in Q4 2025 and held it in 1 quarter. The position peaked at $275K in Q4 2025. 488 funds tracked by Wall St. Rank hold ECG as of Q1 2026.

  • PharVision Advisers reported no remaining Everus Construction Group position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 3,212 Everus Construction Group shares in Q1 2026, an estimated $275K.
  • PharVision Advisers first reported a position in Everus Construction Group in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Everus Construction Group position peaked at $275K in Q4 2025.
  • 488 funds tracked by Wall St. Rank held Everus Construction Group as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.